Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Charytan

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Archives of Internal Medicine|July 1, 1978
Amyloidosis secondary to drug abuse and chronic skin suppurationH Jacob, C Charytan, J H Rascoff, et al.
Nephron|January 1, 1983
Serum thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis and regular hemodialysisB Thysen, M Gatz, R Freeman, et al.
Archives of Internal Medicine|April 1, 1983
Nondilated obstructive nephropathyJ H Rascoff, R A Golden, B S Spinowitz, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1982
Continuous ambulatory peritoneal dialysis: establishment and growth of a program in a large metropolitan areaC Charytan, B S Spinowitz, R A Golden, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1982
Eosinophilic peritonitisB S Spinowitz, R A Golden, J H Rascoff, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1993
Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activatorB K Gupta, B S Spinowitz, C Charytan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 2, 2001
Role of the nephrologist in the intensive care unitC Charytan, A A Kaplan, E P Paganini, et al.
American Journal of Nephrology|December 10, 1998
Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patientsC Charytan, A Goldfarb-Rumyantzev, Y F Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1991
Impact of epoetin beta on dialyzer clearance and heparin requirementsB S Spinowitz, J Arslanian, C Charytan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 7, 2001
Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trialC Charytan, N Levin, M Al-Saloum, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|July 1, 1978
Amyloidosis secondary to drug abuse and chronic skin suppurationH Jacob, C Charytan, J H Rascoff, et al.
Nephron|January 1, 1983
Serum thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis and regular hemodialysisB Thysen, M Gatz, R Freeman, et al.
Archives of Internal Medicine|April 1, 1983
Nondilated obstructive nephropathyJ H Rascoff, R A Golden, B S Spinowitz, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1982
Continuous ambulatory peritoneal dialysis: establishment and growth of a program in a large metropolitan areaC Charytan, B S Spinowitz, R A Golden, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1982
Eosinophilic peritonitisB S Spinowitz, R A Golden, J H Rascoff, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1993
Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activatorB K Gupta, B S Spinowitz, C Charytan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 2, 2001
Role of the nephrologist in the intensive care unitC Charytan, A A Kaplan, E P Paganini, et al.
American Journal of Nephrology|December 10, 1998
Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patientsC Charytan, A Goldfarb-Rumyantzev, Y F Wang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1991
Impact of epoetin beta on dialyzer clearance and heparin requirementsB S Spinowitz, J Arslanian, C Charytan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 7, 2001
Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trialC Charytan, N Levin, M Al-Saloum, et al.
Pageof 4